MENU
KMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

KMB stock forecast, quote, news & analysis

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
Nov 15, 2026

Why Kimberly-Clark (KMB) Stock Is Up +10.1% in the Last 30 Days

Key Takeaways

  • Kimberly-Clark shares climbed roughly 10.1% over the trailing 30 days, rising from about $99.41 to approximately $109.43.
  • The rebound was powered by the completed acquisition of Kenvue (KVUE) and a third-quarter 2026 earnings beat.
  • Q3 2026 adjusted earnings per share from continuing operations reached $1.70, up 17.2% year over year and ahead of consensus.
  • The stock recovered sharply from a September and early October pullback tied to China social-media disruptions and softer organic sales.
  • Over the full quarter, shares remain roughly flat, underscoring the strength of the recent V-shaped recovery from early-October lows.
  • Management reaffirmed its full-year 2026 outlook, anchoring investor sentiment around the Kenvue integration.
  • For additional detail on Kimberly-Clark's Price Targets, Earnings, and Forecast, explore the dedicated pages.
  • Discover how AI-driven strategies are tracking this and other stocks by exploring Trending AI Robots.

Kimberly-Clark (KMB) Company Overview and Market Position

Kimberly-Clark Corporation is a global leader in personal care and tissue products, with an iconic portfolio that includes Huggies, Kotex, Kleenex, Cottonelle, Scott, and Depend. The company serves retail and commercial customers across more than 175 countries, with North America historically representing roughly half of net sales. Its scale, trusted brands, and entrenched distribution have made it a core consumer-staples holding and a member of the S&P 500. Kimberly-Clark is also a dividend aristocrat, having paid a cash dividend for 92 consecutive years and raised it for 54 consecutive years. Investors follow the stock for its defensive earnings profile, reliable dividend, and, more recently, its transformation into a broader consumer-health company through the Kenvue acquisition.

Kimberly-Clark (KMB) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, Kimberly-Clark shares advanced about 10.1%, moving from a closing price near $99.41 in mid-October to roughly $109.43 by mid-November. The advance was not linear: the stock staged a sharp rally in the second half of October, consolidated in early November around the Kenvue closing and earnings release, and finished the period near its recent highs.

The quarterly picture is more nuanced. From mid-August levels near $110, shares sold off through September and into early October, briefly trading below $95, before recovering. As a result, the stock is essentially flat over the trailing three-month window, even as the recent 30-day move has been decisively positive. This pattern reflects a rapid recovery from a short-term dislocation rather than a sustained multi-month uptrend.

What Drove KMB Stock Price in the Last 30 Days

The primary catalyst was the completion of Kimberly-Clark's acquisition of Kenvue, which closed on November 2, 2026. The transaction positions the combined company at the intersection of consumer staples and healthcare, and management has outlined a three-phase "Ready, Set, Grow" integration plan targeting $1.9 billion in cost synergies within three years and $1.4 billion in revenue synergies within four years. Investor enthusiasm around the deal's closure helped lift the stock.

Earnings provided a second pillar of support. On November 5, Kimberly-Clark reported third-quarter 2026 results with non-GAAP earnings per share of $1.70, beating consensus estimates by about $0.05. Net sales of roughly $4.13 billion declined modestly year over year but were broadly in line with forecasts. Adjusted EPS from continuing operations rose 17.2%, driven by lower net interest expense and a lower adjusted effective tax rate. Earlier in the period, preliminary third-quarter results released in mid-October, along with a reaffirmed full-year 2026 outlook, helped stabilize sentiment and set the stage for the rally.

What Drove KMB Stock Performance Over the Last Quarter

The broader three-month trend has been shaped by a September and early October sell-off followed by a sharp recovery. The decline reflected pressure from a previously disclosed China social-media disruption that weighed on organic sales, alongside softer category demand and market-wide rotation within consumer staples. The stock found a bottom near $94 in early October. From there, the combination of preliminary results, a reaffirmed 2026 outlook, the Kenvue acquisition closing, and a third-quarter earnings beat drove the shares back toward the $109–$112 range. The net effect is a largely flat quarterly performance that masks considerable volatility and a meaningful rebound in investor confidence.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots drawn from a broader universe of hundreds of bots that monitor thousands of tickers. Only the top-performing and most relevant strategies appear in this section, with bots differing in trading style, timeframe, and performance metrics. This allows traders and investors to compare automated approaches and evaluate how algorithmic systems are positioning across markets. Those interested in data-driven trading tools can explore the page to review the featured strategies and their recent performance.

KMB Stock Forecast Drivers: What Investors Should Watch Next

Looking ahead, the most important variable is the Kenvue integration. Management expects Kenvue-related EPS dilution of no more than mid-single digits in 2027, followed by double-digit growth in 2028 and a return to the company's long-term earnings algorithm by integration year two. Investors will monitor synergy execution, deleveraging progress, and the company's ability to improve momentum in Kenvue's self-care and essential-care brands.

Other factors to watch include the pace of recovery from the China social-media disruption, raw-material and energy input costs, and currency movements. Management's full-year 2026 outlook calls for organic sales growth roughly 100 basis points below weighted-average category growth of about 1.7%, mid-single-digit constant-currency adjusted operating profit growth, and high-single-digit growth in adjusted continuing-operations EPS. The sustainability of the dividend, with a payout ratio near 86%, remains a key consideration for income-oriented investors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for KMB with price predictions
Nov 20, 2026

KMB's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for KMB moved out of overbought territory on October 26, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 instances where the indicator moved out of the overbought zone. In 19 of the 31 cases the stock moved lower in the days that followed. This puts the odds of a move down at 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KMB as a result. In 45 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.

The Moving Average Convergence Divergence Histogram (MACD) for KMB turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 20 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 45%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

KMB broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

KMB moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for KMB crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 38%.

Following a +3.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where KMB advanced for three days, in 130 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 42%.

The Aroon Indicator entered an Uptrend today. In 84 of 191 cases where KMB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 44%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 12 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. KMB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.607) is normal, around the industry mean (21.731). P/E Ratio (18.409) is within average values for comparable stocks, (16.288). Projected Growth (PEG Ratio) (2.018) is also within normal values, averaging (1.518). Dividend Yield (0.047) settles around the average of (0.032) among similar stocks. P/S Ratio (1.971) is also within normal values, averaging (1.902).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

A.I.Advisor
published Dividends

KMB is expected to pay dividends on January 05, 2027

Kimberly-Clark Corp KMB Stock Dividends
A quarterly dividend of $1.28 per share will be paid with a record date of January 05, 2027, and an ex-dividend date of December 04, 2026. The last dividend of $1.28 was paid on October 02. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 25.17B. The market cap for tickers in the group ranges from 60.48K to 384.17B. PG holds the highest valuation in this group at 384.17B. The lowest valued company is EOSS at 60.48K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -7%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was 18%. FRTT experienced the highest price growth at 18%, while BYAH experienced the biggest fall at -41%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was 79% and the average quarterly volume growth was 80%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 50
Price Growth Rating: 49
SMR Rating: 73
Profit Risk Rating: 86
Seasonality Score: 35 (-100 ... +100)